Synergistic effects and pharmacotherapeutic activity of gemcitabine and cisplatin combination therapy in biliary tract cancer cell lines

(1) National Cancer Center Hospital,Tokyo,Japan

(2) Division of Molecular Pathology, National Cancer Center Research Institute,Tokyo,Japan

(3) Keio University School of Medicine,Tokyo,Japan



This item was part of the Liver and Biliary III (Posters) session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019